203 related articles for article (PubMed ID: 17288877)
1. Lenalidomide: immunomodulatory, antiangiogenic, and clinical activity in solid tumors.
Dreicer R
Curr Oncol Rep; 2007 Mar; 9(2):120-3. PubMed ID: 17288877
[TBL] [Abstract][Full Text] [Related]
2. The potential of immunomodulatory drugs in the treatment of solid tumors.
Dalgleish A; Galustian C
Future Oncol; 2010 Sep; 6(9):1479-84. PubMed ID: 20919830
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.
Krejčík Z; Beličková M; Hruštincová A; Kléma J; Zemanová Z; Michalová K; Čermák J; Jonášová A; Dostálová Merkerová M
Cancer Genet; 2015 Apr; 208(4):156-61. PubMed ID: 25883014
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory drugs in myelodysplastic syndromes.
Galili N; Raza A
Expert Opin Investig Drugs; 2006 Jul; 15(7):805-13. PubMed ID: 16787143
[TBL] [Abstract][Full Text] [Related]
5. [Lenalidomide in hematological malignancies---review].
Jin X; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):205-9. PubMed ID: 22391198
[TBL] [Abstract][Full Text] [Related]
6. A review of the history, properties, and use of the immunomodulatory compound lenalidomide.
Zeldis JB; Knight R; Hussein M; Chopra R; Muller G
Ann N Y Acad Sci; 2011 Mar; 1222():76-82. PubMed ID: 21434945
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide for treatment of myelodysplastic syndromes.
Komrokji RS; List AF
Curr Pharm Des; 2012; 18(22):3198-203. PubMed ID: 22571699
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory drugs in chronic lymphocytic leukemia: a new treatment paradigm.
Molica S
Leuk Lymphoma; 2007 May; 48(5):866-9. PubMed ID: 17487728
[TBL] [Abstract][Full Text] [Related]
9. Lenalidomide - current understanding of mechanistic properties.
Tageja N
Anticancer Agents Med Chem; 2011 Mar; 11(3):315-26. PubMed ID: 21426296
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Aschauer G; Greil R; Linkesch W; Nösslinger T; Stauder R; Burgstaller S; Fiegl M; Fridrik M; Girschikofsky M; Keil F; Petzer A
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):e143-9. PubMed ID: 26422252
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy in myelodysplastic syndromes: is there a role?
Oh ST; Gotlib J
Curr Hematol Malig Rep; 2008 Jan; 3(1):10-8. PubMed ID: 20425441
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q).
Xiong B; Liu X; Zou P; Fan L; Chen W; Li W; Liu L
Leuk Res; 2010 Jul; 34(7):e169-72. PubMed ID: 20122730
[No Abstract] [Full Text] [Related]
13. Lenalidomide in solid tumors.
Segler A; Tsimberidou AM
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1393-406. PubMed ID: 22584909
[TBL] [Abstract][Full Text] [Related]
14. Properties of thalidomide and its analogues: implications for anticancer therapy.
Teo SK
AAPS J; 2005 Mar; 7(1):E14-9. PubMed ID: 16146335
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide: an immunomodulatory drug.
Crane E; List A
Future Oncol; 2005 Oct; 1(5):575-83. PubMed ID: 16556034
[TBL] [Abstract][Full Text] [Related]
16. [IMiDs in hematology].
Wémeau M; Gauthier J; Leleu X; Yakoub-Agha I
Bull Cancer; 2011 Aug; 98(8):879-87. PubMed ID: 21827980
[TBL] [Abstract][Full Text] [Related]
17. IMiDs: a novel class of immunomodulators.
Knight R
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S24-30. PubMed ID: 16085014
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide as a novel treatment of acute myeloid leukemia.
Chen Y; Borthakur G
Expert Opin Investig Drugs; 2013 Mar; 22(3):389-97. PubMed ID: 23316859
[TBL] [Abstract][Full Text] [Related]
19. [Action mechanism of lenalidomide in hematological malignancies - review].
Liu LR; Qian SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):1039-41. PubMed ID: 22931680
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory drugs in the treatment of myelodysplastic syndromes.
Ortega J; List A
Curr Opin Oncol; 2007 Nov; 19(6):656-9. PubMed ID: 17906467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
